165 related articles for article (PubMed ID: 37759731)
1. FOXM1a Isoform of Oncogene FOXM1 Is a Tumor Suppressor Suppressed by hnRNP C in Oral Squamous Cell Carcinoma.
Jia R; Che X; Jia J; Guo J
Biomolecules; 2023 Aug; 13(9):. PubMed ID: 37759731
[TBL] [Abstract][Full Text] [Related]
2. Inclusion of hnRNP L Alternative Exon 7 Is Associated with Good Prognosis and Inhibited by Oncogene SRSF3 in Head and Neck Squamous Cell Carcinoma.
Xu L; Shen J; Jia J; Jia R
Biomed Res Int; 2019; 2019():9612425. PubMed ID: 31828152
[TBL] [Abstract][Full Text] [Related]
3. HnRNP L is important for the expression of oncogene SRSF3 and oncogenic potential of oral squamous cell carcinoma cells.
Jia R; Zhang S; Liu M; Zhang Y; Liu Y; Fan M; Guo J
Sci Rep; 2016 Nov; 6():35976. PubMed ID: 27808105
[TBL] [Abstract][Full Text] [Related]
4. FOXM1-Mediated Regulation of Reactive Oxygen Species and Radioresistance in Oral Squamous Cell Carcinoma Cells.
Takeshita H; Yoshida R; Inoue J; Ishikawa K; Shinohara K; Hirayama M; Oyama T; Kubo R; Yamana K; Nagao Y; Gohara S; Sakata J; Nakashima H; Matsuoka Y; Nakamoto M; Hirayama M; Kawahara K; Takahashi N; Hirosue A; Kuwahara Y; Fukumoto M; Toya R; Murakami R; Nakayama H
Lab Invest; 2023 May; 103(5):100060. PubMed ID: 36801643
[TBL] [Abstract][Full Text] [Related]
5. HnRNP C, YB-1 and hnRNP L coordinately enhance skipping of human MUSK exon 10 to generate a Wnt-insensitive MuSK isoform.
Nasrin F; Rahman MA; Masuda A; Ohe K; Takeda J; Ohno K
Sci Rep; 2014 Oct; 4():6841. PubMed ID: 25354590
[TBL] [Abstract][Full Text] [Related]
6. Retinoids induce antagonism between FOXO3A and FOXM1 transcription factors in human oral squamous cell carcinoma (OSCC) cells.
Osei-Sarfo K; Gudas LJ
PLoS One; 2019; 14(4):e0215234. PubMed ID: 30978209
[TBL] [Abstract][Full Text] [Related]
7. Identification of a prognostic alternative splicing signature in oral squamous cell carcinoma.
Zhang S; Wu X; Diao P; Wang C; Wang D; Li S; Wang Y; Cheng J
J Cell Physiol; 2020 May; 235(5):4804-4813. PubMed ID: 31637730
[TBL] [Abstract][Full Text] [Related]
8. Gain-of-function mutant p53 promotes the oncogenic potential of head and neck squamous cell carcinoma cells by targeting the transcription factors FOXO3a and FOXM1.
Tanaka N; Zhao M; Tang L; Patel AA; Xi Q; Van HT; Takahashi H; Osman AA; Zhang J; Wang J; Myers JN; Zhou G
Oncogene; 2018 Mar; 37(10):1279-1292. PubMed ID: 29269868
[TBL] [Abstract][Full Text] [Related]
9. Identification of RNA-splicing factor Lsm12 as a novel tumor-associated gene and a potent biomarker in Oral Squamous Cell Carcinoma (OSCC).
Dong Y; Xue L; Zhang Y; Liu C; Zhang Y; Jiang N; Ma X; Chen F; Li L; Yu L; Liu X; Shao S; Guan S; Zhang J; Xiao Q; Li H; Dong A; Huang L; Shi C; Wang Y; Fu M; Lv N; Zhan Q
J Exp Clin Cancer Res; 2022 Apr; 41(1):150. PubMed ID: 35449073
[TBL] [Abstract][Full Text] [Related]
10. Oral squamous cancer cell exploits hnRNP A1 to regulate cell cycle and proliferation.
Yu C; Guo J; Liu Y; Jia J; Jia R; Fan M
J Cell Physiol; 2015 Sep; 230(9):2252-61. PubMed ID: 25752295
[TBL] [Abstract][Full Text] [Related]
11. Dysregulated expression of FOXM1 isoforms drives progression of pancreatic cancer.
Kong X; Li L; Li Z; Le X; Huang C; Jia Z; Cui J; Huang S; Wang L; Xie K
Cancer Res; 2013 Jul; 73(13):3987-96. PubMed ID: 23598278
[TBL] [Abstract][Full Text] [Related]
12. PCBP1 inhibits the expression of oncogenic STAT3 isoform by targeting alternative splicing of STAT3 exon 23.
Wang X; Guo J; Che X; Jia R
Int J Biol Sci; 2019; 15(6):1177-1186. PubMed ID: 31223278
[TBL] [Abstract][Full Text] [Related]
13. The transcription factor FOXM1 regulates the balance between proliferation and aberrant differentiation in head and neck squamous cell carcinoma.
Roh V; Hiou-Feige A; Misetic V; Rivals JP; Sponarova J; Teh MT; Ferreira Lopes S; Truan Z; Mermod M; Monnier Y; Hess J; Tolstonog GV; Simon C
J Pathol; 2020 Jan; 250(1):107-119. PubMed ID: 31465124
[TBL] [Abstract][Full Text] [Related]
14. FOXM1 is a novel predictor of recurrence in patients with oral squamous cell carcinoma associated with an increase in epithelial‑mesenchymal transition.
Luo YD; Ding X; Du HM; Wu YN; Li HQ; Wu HM; Zhang XM
Mol Med Rep; 2019 May; 19(5):4101-4108. PubMed ID: 30942437
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneous ribonucleoprotein C displays a repressor activity mediated by T-cell intracellular antigen-1-related/like protein to modulate Fas exon 6 splicing through a mechanism involving Hu antigen R.
Izquierdo JM
Nucleic Acids Res; 2010 Dec; 38(22):8001-14. PubMed ID: 20699271
[TBL] [Abstract][Full Text] [Related]
16. FOXM1 promotes hepatocellular carcinoma progression by regulating KIF4A expression.
Hu G; Yan Z; Zhang C; Cheng M; Yan Y; Wang Y; Deng L; Lu Q; Luo S
J Exp Clin Cancer Res; 2019 May; 38(1):188. PubMed ID: 31072351
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic Control of Cancer Cell Proliferation and Cell Cycle Progression by HNRNPK via Promoting Exon 4 Inclusion of Histone Code Reader SPIN1.
Li D; Guo J; Jia R
J Mol Biol; 2023 Mar; 435(6):167993. PubMed ID: 36736887
[TBL] [Abstract][Full Text] [Related]
18. SRSF3-Mediated Ki67 Exon 7-Inclusion Promotes Head and Neck Squamous Cell Carcinoma Progression via Repressing AKR1C2.
Liu M; Lin C; Huang Q; Jia J; Guo J; Jia R
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835286
[TBL] [Abstract][Full Text] [Related]
19. Splicing factor hnRNP A2 activates the Ras-MAPK-ERK pathway by controlling A-Raf splicing in hepatocellular carcinoma development.
Shilo A; Ben Hur V; Denichenko P; Stein I; Pikarsky E; Rauch J; Kolch W; Zender L; Karni R
RNA; 2014 Apr; 20(4):505-15. PubMed ID: 24572810
[TBL] [Abstract][Full Text] [Related]
20. RRM but not the Asp/Glu domain of hnRNP C1/C2 is required for splicing regulation of Ron exon 11 pre-mRNA.
Moon H; Jang HN; Liu Y; Choi N; Oh J; Ha J; Kim HH; Zheng X; Shen H
BMB Rep; 2019 Nov; 52(11):641-646. PubMed ID: 31401978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
